| Liquid formulations of glucagon analogs |
2022-10-11 |
2022-10-21 |
|
| Fluid Delivery and Measurement Systems and Methods |
2022-6-16 |
2022-10-06 |
|
| Kv1.3 blockers |
2022-3-22 |
2022-9-29 |
|
| Kv1.3 blockers |
2022-3-13 |
2022-5-01 |
|
| CYCLIC PEPTIDES MULTIMERS TARGETING α4β7 INTEGRIN |
2022-3-02 |
2022-5-24 |
|
| Composition for treating short bowel syndrome |
2022-2-17 |
2022-8-25 |
|
| Time Delay Mechanism for a Hydraulic Drug Delivery Device |
2022-2-11 |
2022-5-26 |
|
| Pharmaceutical composition of glp-1/glp-2 dual agonists |
2021-12-16 |
2022-6-23 |
|
| Pharmaceutical composition of glp-1/glp-2 dual agonists |
2021-12-16 |
2022-8-01 |
|
| Pharmaceutical composition of glp-1/glp-2 dual agonists |
2021-12-16 |
2022-6-23 |
|
| Use of glp-2 analogues in patients with renal insufficiency |
2021-12-15 |
2022-6-23 |
|
| Parenteral Pharmaceutical Composition of Dual Glp1/2 Agonist |
2021-12-09 |
2022-7-22 |
|
| Multi-Cartridge Fluid Delivery Device |
2021-10-01 |
2022-1-20 |
|
| Glucagon analogues |
2021-9-09 |
2022-2-07 |
|
| Glucagon-glp-1-gip triple agonist compounds |
2021-7-29 |
2021-11-25 |
|
| Amylin analogues |
2021-7-21 |
2021-11-11 |
|
| Acylated glucagon analogues |
2021-7-07 |
2022-3-10 |
|
| Compounds targeting alpha4-beta7 1ntegrin |
2021-6-25 |
2022-1-06 |
|
| TARGETING COMPOUNDS OF INTEGRIN a4b7 |
2021-6-25 |
2022-10-05 |
|
| GIP agonist compounds and methods |
2021-6-08 |
2021-9-16 |
|
| Glp-1/glp-2 dual agonists |
2021-3-29 |
2021-10-07 |
|
| Agonist combination |
2021-3-29 |
2021-10-07 |
|
| Cyclic peptides targeting alpha-4-beta-7 integrin |
2021-3-26 |
2021-9-30 |
|
| Formulations of glucagon-like peptide 2 (glp-2) analogs |
2021-3-19 |
2021-8-06 |
|
| Glucagon-like-peptide-2 (glp-2) analogues |
2021-1-21 |
2021-10-07 |
|
| Hepcidin analogues and uses thereof |
2020-11-16 |
2022-11-03 |
|
| Amylin analogues |
2020-8-06 |
2021-4-22 |
|
| Adapter for a fluid transfer device |
2020-8-05 |
2022-9-22 |
|
| Moving Basal Engine For A Fluid Delivery Device |
2020-7-28 |
2020-11-26 |
|
| Apparatus and methods for administering a pharmaceutical agent |
2020-7-22 |
2021-3-11 |
|
| Pharmaceutical composition for subcutaneous administration |
2020-7-15 |
2022-8-04 |
|
| Acylated GLP-1/GLP-2 dual agonists |
2020-4-06 |
2022-7-26 |
2022-7-26 |
| A fluid delivery device having an insertable prefilled cartridge |
2020-3-10 |
2020-3-26 |
|
| GLUCAGON ANALOGUES |
2020-1-30 |
2021-1-27 |
|
| Dosages for the administration of glucagon-2-like peptide analogs (glp-2). |
2019-12-13 |
2020-5-04 |
|
| GIP-GLP-1 dual agonist compounds and methods |
2019-11-22 |
2020-3-19 |
|
| Hydraulically Actuated Pump for Fluid Administration |
2019-11-18 |
2020-3-19 |
|
| Gap junction intercellular communication modulators and their use for the … |
2019-10-30 |
2021-7-29 |
|
| Formulations of glucagon-like-peptide-2 (glp-2) analogues |
2019-9-27 |
2020-4-02 |
|
| Fluid delivery device |
2019-9-20 |
2021-1-14 |
2021-1-14 |
| Therapeutic uses of glp-2 agonists |
2019-7-23 |
2020-1-30 |
|
| Fluid Delivery Device Needle Retraction Mechanisms, Cartridges and Expandable … |
2019-6-24 |
2019-10-10 |
|
| Acylated glucagon analogue |
2019-5-13 |
2022-3-15 |
2022-3-15 |
| Cartridge Insertion Mechanism for a Fluid Delivery Device |
2019-4-18 |
2019-8-08 |
|
| Hydraulically actuated pump for long duration medicament administration |
2019-2-28 |
2020-7-23 |
2020-7-23 |
| COMPSTATIN analogues and their medical uses |
2019-2-27 |
2020-1-01 |
|
| Needle control and drug mixing systems for a fluid delivery device |
2018-10-11 |
2019-11-07 |
2019-11-07 |
| Gip-glp-1 dual agonist compounds and methods |
2018-9-05 |
2019-5-09 |
|
| Communication accessory for a drug delivery device |
2018-7-13 |
2021-6-23 |
|
| Methods and medical uses relating to the treatment of hypoglycemia |
2018-7-04 |
2020-5-08 |
|
| DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-PEPTIDE-2 (GLP-2) ANALOGUES |
2018-6-15 |
2019-9-18 |
|
| Acylated glucagon analogues |
2018-5-22 |
2019-3-14 |
|
| Glucagon analogues |
2018-5-18 |
2019-2-21 |
|
| Homodetic cyclic peptides targeting alpha-4-beta-7 integrin |
2018-5-10 |
2022-3-29 |
2022-3-29 |
| Glucagon-like-peptide-2 (GLP-2) analogues |
2018-4-11 |
2019-4-09 |
2019-4-09 |
| Dosage regimes for the administration of glucagon-like-peptide-2 (GLP-2) … |
2018-1-19 |
2018-3-07 |
|
| Glp-1/glp-2 dual agonists |
2017-12-11 |
2018-6-14 |
|
| Glp-1/glp-2 dual agonists. |
2017-12-11 |
2019-8-01 |
|
| Acylated glp-1/glp-2 dual agonists |
2017-12-11 |
2018-6-14 |
|
| Dosage regimes for the administration of Glucagon-Like Peptide-2(GLP-2) … |
2017-9-05 |
2017-10-18 |
|
| Fluid delivery device needle retraction mechanisms, cartridges and expandable … |
2017-9-01 |
2019-1-24 |
2019-1-24 |
| Ghrelin analogues |
2017-4-12 |
2018-1-11 |
|
| Use of elsiglutide to treat gastrointestinal mucositis that includes … |
2017-3-08 |
2017-9-29 |
|
| Glucagon-like-peptide-2 (glp-2) analogues |
2017-1-20 |
2017-5-18 |
|
| Peptide conjugates of GLP-1 receptor agonists and gastrin and their use |
2016-12-16 |
2019-9-10 |
2019-9-10 |
| Acylated glp-1/glp-2 dual agonists |
2016-12-09 |
2018-6-14 |
|
| Glucagon analogues |
2016-8-17 |
2016-12-01 |
|
| Methods of treating damage after a stroke |
2016-7-07 |
2017-1-19 |
|
| Glucagon analogues |
2016-6-27 |
2016-10-20 |
|
| Fluid transfer device |
2016-5-26 |
2017-12-05 |
2017-12-05 |
| Treatment of cardiac disease |
2016-4-01 |
2016-8-04 |
|
| GIP AGONIST COMPOUNDS AND METHODS |
2015-10-29 |
2017-3-01 |
|
| GLP-1 receptor agonist peptide gastrin conjugates |
2015-9-24 |
2018-1-09 |
2018-1-09 |
| Combination of acylated glucagon analogues with insulin analogues |
2015-9-17 |
2016-1-07 |
|
| Glucagon analogues |
2015-9-14 |
2015-12-31 |
|
| Multi-cartridge fluid delivery device |
2015-8-03 |
2017-6-29 |
2017-6-29 |
| ACYLYCED GLUCAGON ANALOGS |
2015-5-28 |
2017-2-08 |
|
| Glucagon analogues |
2015-5-05 |
2015-10-30 |
|
| GLUCAGON ANALOGUES |
2015-3-16 |
2015-12-31 |
|
| Fluid delivery device needle retraction mechanisms, cartridges and expandable … |
2014-12-17 |
2016-9-08 |
2016-9-08 |
| Synthesis of pyrrolidine compounds |
2014-12-16 |
2016-10-18 |
2016-10-18 |
| DUAL AGONIST COMPOUNDS OF GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) / … |
2014-11-06 |
2016-5-26 |
|
| GIP-GLP-1 dual agonist compounds and methods |
2014-11-06 |
2016-5-12 |
|